MOH — authorised 26 May 2023
- Marketing authorisation holder: LEXICON PHARMS INC
- Status: likely_approved
MOH authorised Inpefa on 26 May 2023
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 26 May 2023.
LEXICON PHARMS INC holds the Israeli marketing authorisation.